Clomethiazole

This classification denotes a sedative and hypnotic with the molecular formula C6H8ClNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0C5DBZ19HV, chemically known as thiazole, 5-(2-chloroethyl)-4-methyl- but generally known as clomethiazole, which bears US NIH Compound Identifier 10783. European Medicines Agency schedules Clomethiazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06720MIG. The term CLOMETHIAZOLE is an International Non-Proprietary Name. World Health Organization schedules clomethiazole in its Anatomical Therapeutic Chemical (ATC) Classification. CLOMETHIAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clomethiazole under HS 29341000 and SITC 51579. As of Q4 2014, CLOMETHIAZOLE remains the US FDA Preferred Term for this commodity. Clomethiazole bears US NLM identifiers UMLS ID C0008221 and NCI Concept Code C80664. SMILES: CC1=C(SC=N1)CCCL.